| Copper(II) sulfate is an inorganic compound with the chemical formula CuSO4. It forms hydrates CuSO4·nH2O, where n can range from 1 to 7. The pentahydrate (n = 5), a bright blue crystal, is the most commonly encountered hydrate of copper(II) sulfate, while its anhydrous form is white. Older names for the pentahydrate include blue vitriol, bluestone, vitriol of copper, and Roman vitriol. It exothermically dissolves in water to give the aquo complex [Cu(H2O)6]2+, which has octahedral molecular geometry. The structure of the solid pentahydrate reveals a polymeric structure wherein copper is again octahedral but bound to four water ligands. The Cu(II)(H2O)4 centers are interconnected by sulfate anions to form chains.
|
|
Read full article at Wikipedia
|
| InChI=1S/C8H20NO6P/c1-9(2,3)4-5-14-16(12,13)15-7-8(11)6-10/h8,10-11H,4-7H2,1-3H3/t8-/m1/s1 |
| SUHOQUVVVLNYQR-MRVPVSSYSA-N |
| C[N+](C)(C)CCOP([O-])(=O)OC[C@H](O)CO |
|
|
Mus musculus
(NCBI:txid10090)
|
Source: BioModels - MODEL1507180067
See:
PubMed
|
|
Saccharomyces cerevisiae
(NCBI:txid4932)
|
Source: yeast.sf.net
See:
PubMed
|
|
Escherichia coli
(NCBI:txid562)
|
See:
PubMed
|
|
Homo sapiens
(NCBI:txid9606)
|
See:
DOI
|
|
Escherichia coli metabolite
Any bacterial metabolite produced during a metabolic reaction in Escherichia coli.
Saccharomyces cerevisiae metabolite
Any fungal metabolite produced during a metabolic reaction in Baker's yeast (Saccharomyces cerevisiae ).
human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
parasympatholytic
Any cholinergic antagonist that inhibits the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the muscarinic antagonists.
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
|
|
|
parasympatholytic
Any cholinergic antagonist that inhibits the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the muscarinic antagonists.
neuroprotective agent
Any compound that can be used for the treatment of neurodegenerative disorders.
|
|
View more via ChEBI Ontology
|
(2R)-2,3-dihydroxypropyl 2-(trimethylazaniumyl)ethyl phosphate
|
2- {[(2R)-2,3-dihydroxypropoxy](hydroxy)phosphoryloxy}-N,N,N-trimethylethanaminium
|
alfoscerate de choline
|
ChemIDplus
|
alfoscerato de colina
|
ChemIDplus
|
|
choline alfoscerate
|
ChemIDplus
|
|
choline alfoscerate
|
KEGG DRUG
|
cholini alfosceras
|
ChemIDplus
|
|
(2R)-2,3-dihydroxypropyl 2-(trimethylammonio)ethyl phosphate
|
IUPAC
|
|
alpha-Glycerophosphorylcholine
|
HMDB
|
|
Choline alphoscerate
|
ChemIDplus
|
|
Choline glycerophosphate
|
ChemIDplus
|
|
Cholini glycerophosphas
|
ChemIDplus
|
|
Glicerofosfato de colina
|
ChemIDplus
|
|
Glycerol phosphorylcholine
|
HMDB
|
|
Glycerol-3-phosphatidylcholine
|
HMDB
|
|
glycerol-3-phosphocholine
|
ChEBI
|
|
Glycerophosphate de choline
|
ChemIDplus
|
|
Glycerophosphocholine
|
ChemIDplus
|
|
Glycerophosphocholine
|
KEGG COMPOUND
|
|
Glycerophosphocholine
|
KEGG COMPOUND
|
|
Glycerophosphorylcholine
|
ChemIDplus
|
|
GPCho
|
HMDB
|
|
L-alpha-Glycerophosphocholine
|
ChemIDplus
|
|
L-alpha-Glycerophosphorylcholine
|
ChemIDplus
|
|
L-alpha-Glycerophosphorylcholine
|
HMDB
|
|
L-Choline hydroxide 2,3-dihydroxypropyl hydrogen phosphate inner salt
|
HMDB
|
|
sn-3-GPC
|
MetaCyc
|
|
sn-Glycero-3-phosphocholine
|
ChemIDplus
|
|
sn-glycero-3-phosphocholine
|
ChEBI
|
|
sn-glycero-3-phosphocholine
|
ChEBI
|
|
sn-glycerol 3-phosphocholine
|
UniProt
|
|
28319-77-9
|
CAS Registry Number
|
ChemIDplus
|
|
28319-77-9
|
CAS Registry Number
|
KEGG DRUG
|
|
3908444
|
Reaxys Registry Number
|
Reaxys
|
|
6062450
|
Beilstein Registry Number
|
Beilstein
|
|
